1. Home
  2. IZEA vs INKT Comparison

IZEA vs INKT Comparison

Compare IZEA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZEA
  • INKT
  • Stock Information
  • Founded
  • IZEA 2006
  • INKT 2017
  • Country
  • IZEA United States
  • INKT United States
  • Employees
  • IZEA N/A
  • INKT N/A
  • Industry
  • IZEA Advertising
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • IZEA Consumer Discretionary
  • INKT Health Care
  • Exchange
  • IZEA Nasdaq
  • INKT Nasdaq
  • Market Cap
  • IZEA 29.1M
  • INKT 28.9M
  • IPO Year
  • IZEA N/A
  • INKT 2021
  • Fundamental
  • Price
  • IZEA $2.94
  • INKT $55.25
  • Analyst Decision
  • IZEA
  • INKT Strong Buy
  • Analyst Count
  • IZEA 0
  • INKT 2
  • Target Price
  • IZEA N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • IZEA 48.9K
  • INKT 14.8K
  • Earning Date
  • IZEA 08-13-2025
  • INKT 08-12-2025
  • Dividend Yield
  • IZEA N/A
  • INKT N/A
  • EPS Growth
  • IZEA N/A
  • INKT N/A
  • EPS
  • IZEA N/A
  • INKT N/A
  • Revenue
  • IZEA $36,896,490.00
  • INKT N/A
  • Revenue This Year
  • IZEA $22.24
  • INKT N/A
  • Revenue Next Year
  • IZEA N/A
  • INKT N/A
  • P/E Ratio
  • IZEA N/A
  • INKT N/A
  • Revenue Growth
  • IZEA 7.17
  • INKT N/A
  • 52 Week Low
  • IZEA $1.68
  • INKT $4.56
  • 52 Week High
  • IZEA $3.15
  • INKT $13.79
  • Technical
  • Relative Strength Index (RSI)
  • IZEA 68.32
  • INKT 57.39
  • Support Level
  • IZEA $2.55
  • INKT $6.80
  • Resistance Level
  • IZEA $2.71
  • INKT $7.88
  • Average True Range (ATR)
  • IZEA 0.16
  • INKT 0.40
  • MACD
  • IZEA 0.02
  • INKT 0.02
  • Stochastic Oscillator
  • IZEA 80.00
  • INKT 58.86

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: